Datelliptium chloride

CAS : 105118-14-7

Ref. 3D-FEA11814

Informations sur le produit

• Nom: Datelliptium chloride
• Synonymes: Datelliptium chloride [INN], 2-(2-(Diethylamino)ethyl)-9-hydroxy-5,11-dimethyl-6H-pyrido(4,3-b)carbazolium chloride, Chlorure de datelliptium, Chlorure de datelliptium [French], Cloruro de dateliptio, Cloruro de dateliptio [Spanish], Datelliptii chloridum, Datelliptii chloridum [Latin], N-2-(Diethylaminoethyl)-9-hydroxyellipticinum chloride, Unii-L374Y6We0D, Unii-V5Qkf7Q20O, 2-[2-(diethylamino)ethyl]-9-hydroxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-2-ium chloride

Description

Datelliptium chloride is a polylactic acid implant that is implanted in the pancreas. It has been shown to inhibit tumor growth by inhibiting cell growth and inducing apoptosis. Datelliptium chloride has also been shown to interfere with the absorption process of glucose in the body, which leads to increased serum bilirubin levels and decreased serum glucose levels. The treatment effect of datelliptium chloride on patients with prostate carcinoma was investigated using xenograft tumor models. These studies have demonstrated that datelliptium chloride inhibits tumor cell growth and induces apoptosis, leading to a reduction in size of the xenograft tumors.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 397.94 g/mol
• Formule: C₂₃H₂₈ClN₃O
• Degré de pureté: Min. 95%